We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » MHRA Hits Indian Drugmaker Over GMP Deficiencies
British authorities are ordering an Indian manufacturer to recall batches of progesterone injections after an inspection turned up one critical GMP violation and three major ones at one of its facilities.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor